Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Tandospirone Citrate in the Treatment of Patients With Generalized Anxiety Disorder (TACGAD)

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2012 by Sumitomo Pharmaceutical (Suzhou) Co., Ltd..
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
Sumitomo Pharmaceutical (Suzhou) Co., Ltd.
ClinicalTrials.gov Identifier:
NCT01614041
First received: November 11, 2011
Last updated: February 19, 2013
Last verified: June 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2014
  Estimated Primary Completion Date: January 2014 (Final data collection date for primary outcome measure)